Skip to main content

Boston Scientific Corp(BSX-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low54.31
Day High55.22
Open:55.03
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Elliott Wave Forecast
Will Boston Scientific Corporation (BSX) Continue Further upside?
Motley Fool
Could Ozempic Harm These 3 Medical Device Stocks?
AllPennyStocks.com
Microcap Offers Unique Opportunity for Investors In $10 Billion SCI Industry
Barchart
3 Top-Rated Growth Stocks To Buy on Every Dip
PR Newswire
Boston Scientific Announces Conference Call Discussing Third Quarter 2023 Results
Barchart
Surging Bond Yields Hammer Stocks
PR Newswire
CVS Health appoints Michael F. Mahoney to its Board of Directors
Barchart
Stocks Slump as Bond Yields Climb on the Hawkish Fed Pause
Barchart
Stocks Push Higher Ahead of FOMC and Powell Comments
PR Newswire
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
PR Newswire
Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device
PR Newswire
Boston Scientific Announces 2023 Investor Day Meeting and Conference Call Discussing Third Quarter 2023 Results
Barchart
How to Become Landlord of Your Stock Portfolio
MarketBeat
A Significant Reversal is in Sight for These 5 Med Tech Companies
Barchart
Stocks Rally on Improved Prospects for a Pause in Fed Rate Hikes
MarketBeat
5 Good Reasons it's Time to Buy High-Yield Dividend King 3M
Barchart
Stock Index Futures Muted as Investors Await Key U.S. Economic Data
Barchart
Stocks Close Higher as Bond Yields Decline
Barchart
Stocks Gain as Lower Bond Yields Boost Market Sentiment
Barchart
Markets Today: Stock Climb and Bond Yields Fall as Interest Rate Concerns Ease
PR Newswire
ADVENT Study of the FARAPULSE™ Pulsed Field Ablation System Meets Primary Efficacy and Safety Endpoints
Barchart
Navigate Market Volatility: 3 Iron Condor Trade Ideas for August 22nd
PR Newswire
Boston Scientific Receives FDA Approval for the POLARx™ Cryoablation System
PR Newswire
BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR SECOND QUARTER 2023
PR Newswire
Boston Scientific Elects Dr. Jessica L. Mega and Susan E. Morano to Board of Directors
MarketBeat
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
MarketBeat
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
Barchart
Stocks Pressured by Hawkish Fed But Close Mostly Higher
Barchart
Stocks Move Lower After Fed Meeting
The Globe and Mail
How fund managers are playing the AI-fuelled tech rally
PR Newswire
Boston Scientific Announces Conversion Date of Series A Mandatory Convertible Preferred Stock
MarketBeat
Intuitive Surgical Gives Buying Opportunity Off Its 52 Week Highs

Profile

Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2023 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.